 |
  |
| Author |
Message |
Yahoo News Bot
Joined: 01 Feb 2005
Posts: 33350
|
Posted:
Mon Aug 18, 2008 11:15 am |
  |
AP - Federal regulators are working on a stronger label for a widely used diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. after deaths continue to be reported despite earlier government warnings.
Read more... |
|
|
|
 |
|
|
| |